Safety is evaluated through preclinical and clinical studies, post-marketing surveillance, and patient feedback. Preclinical studies often involve laboratory and animal testing to identify potential risks before human trials. Clinical trials in humans are conducted in phases, starting with small groups to assess safety before progressing to larger populations. Post-marketing surveillance involves ongoing monitoring of adverse events once the treatment is widely available.
